GTXI GTx, Inc.

4.25
0  -2%
Previous Close 4.35
Open 4.34
Price To book 3.48
Market Cap 68.17M
Shares 16,041,000
Volume 5,077
Short Ratio 4.16
Av. Daily Volume 17,340

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

CRL issued November 2, 2009.
Toremifene
Reduce fractures in men with prostate cancer
Phase 2 prelim data from Stage 1 portion of trial due 2Q 2017.
Enobosarm
Breast cancer - advanced AR+ TNBC
Phase 2 initiated January 2016. Data are due 3Q 2017.
Enobosarm
Postmenopausal women with stress urinary incontinence (SUI)
Phase 2 initial data released December, 8 2016. Top-line data due 3Q 2017.
Enobosarm
Breast cancer - metastatic or locally advanced, ER+/AR+ breast cancer

Latest News

  1. GTx reports 4Q loss
  2. GTx Provides Corporate Update and Reports Fourth Quarter and Year-End 2016 Financial Results
  3. GTx, Inc. to Report Fourth Quarter and Full Year 2016 Financial Results on March 15, 2017
  4. Is GTx, Inc. (GTXI) A Good Stock To Buy?
  5. GTx Reports Results from Ongoing Enobosarm Phase 2 Clinical Trial in ER+/AR+ Breast Cancer
  6. GTx Declares 1-For-10 Reverse Stock Split (GTXI)
  7. GTx, Inc. Announces 1-for-10 Reverse Stock Split
  8. GTx, Inc. :GTXI-US: Earnings Analysis: Q3, 2016 By the Numbers : December 1, 2016
  9. Enobosarm Meets Pre-Specified Primary Efficacy Endpoint in Ongoing Phase 2 Clinical Trial in ER+/AR+ Breast Cancer
  10. GTx Announces Webcast of Corporate Presentation at the 28th Annual Piper Jaffray Healthcare Conference
  11. Blog Coverage GTx Inc. Enobosarm Achieves Stage 1 Milestone
  12. GTx Achieves Second Stage 1 Milestone in Phase 2 Clinical Trial of Enobosarm in ER+/AR+ Breast Cancer
  13. GTx Announces Webcast of Corporate Presentation at the Stifel 2016 Healthcare Conference
  14. GTx Provides Corporate Update and Reports Third Quarter 2016 Financial Results
  15. Insider Invests in GTx
  16. GTx Announces $14.0 Million Registered Direct Common Stock Offering
  17. GTx Announces Webcast of Corporate Presentation at Baird’s 2016 Healthcare Conference
  18. GTx Appoints Dr. Garry Neil to Board of Directors